000 | nab a22 7a 4500 | ||
---|---|---|---|
999 |
_c16027 _d16027 |
||
003 | PC16027 | ||
005 | 20210625062818.0 | ||
008 | 200706b xxu||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_92167 _aRuiz Hurtado, Gema _eInstituto de Investigación i+12 |
||
100 |
_9539 _aRuilope Urioste, Luis Miguel _eNefrología |
||
245 | 0 | 0 |
_aDoes cardiovascular protection translate into renal protection?. _h[artículo] |
260 |
_bNature reviews. Cardiology, _c2014 |
||
300 | _a11(12):742-6. | ||
500 | _aFormato Vancouver: Ruiz-Hurtado G, Ruilope LM. Does cardiovascular protection translate into renal protection? Nat Rev Cardiol. 2014 Dec;11(12):742-6. | ||
501 | _aPMID: 25001251 | ||
504 | _aContiene 45 referencias | ||
520 | _aCardiovascular and renal disease often have similar origins and shared risk factors. With the progression of chronic kidney disease (CKD), additional risk factors develop, contributing to the evolution of both diseases. Progression of CKD has been primarily investigated in patients with established diabetic nephropathy and severely increased albuminuria, in cohorts smaller than those necessary for studies of cardiovascular outcomes. Consequently, simultaneous cardiovascular and renal protection was not demonstrated clearly in these studies. Nevertheless, data from some clinical trials in the field of arterial hypertension have demonstrated that cardiovascular and renal protection can be attained using the same therapy. Further investigation on factors that promote rapid progression of cardiovascular disease and CKD should result in new therapies to improve the outcome of patients presenting with both diseases. | ||
710 |
_9625 _aInstituto de Investigación imas12 |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16027.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |